CoChat

State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects

Francois, Amaury, Kerckhove, Nicolas, Meleine, Mathieu, Alloui, Abdelkrim, Barrere, Christian, Gelot, Agathe, Uebele, Victor N., Renger, John J., Eschalier, Alain, Ardid, Denis, Bourinet, Emmanuel · 2013 · Pain
Cited by 120

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

T-type calcium channels encoded by the Ca(V)3.2 isoform are expressed in nociceptive primary afferent neurons where they contribute to hyperalgesia and thus are considered as a potential therapeutic target to treat pathological pain. Here we report that the small organic state-dependent T-type channel antagonist TTA-A2 efficiently inhibits recombinant and native Ca(V)3.2 currents. Although TTA-A2 is a pan Ca(V)3 blocker, it demonstrates a higher potency for Ca(V)3.2 compared to Ca(V)3.1. TTA-A2 selectivity for T-type currents was demonstrated in sensory neurons where it lowered cell excitability uniquely on neurons expressing T-type channels. In vivo pharmacology in Ca(V)3.2 knockout and wild type mice reveal that TTA-A2-mediated antinociception critically depends on Ca(V)3.2 expression. The pathophysiology of irritable bowel syndrome (IBS) was recently demonstrated to involve Ca(V)3.2 in a rat model of this disease. Oral administration of TTA-A2 produced a dose-dependent reduction of hypersensitivity in an IBS model, demonstrating its therapeutic potential for the treatment of pathological pain. Overall, our results suggest that the high potency of TTA-A2 in the depolarized state strengthen its analgesic efficacy and selectivity toward pathological pain syndromes. This characteristic would be beneficial for the development of analgesics targeting T-type channels, in particular for the treatment of pain associated with IBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pain.2012.10.023

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 46

  1. Amir, 1999, Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain., J Neurosci, 19, 8589, 10.1523/JNEUROSCI.19-19-08589.1999 · DOI · Paper page
  2. Beedle, 2004, Agonist-independent modulation of N-type calcium channels by ORL1 receptors., Nat Neurosci, 7, 118, 10.1038/nn1180 · DOI
  3. Bezprozvanny, 1995, Voltage-dependent blockade of diverse types of voltage-gated Ca2 channels expressed in Xenopus oocytes by the Ca2 channel antagonist mibefradil (Ro 40-5967)., Mol Pharmacol, 48, 540, 10.1016/S0026-895X(25)10504-X · DOI · Paper page
  4. Bourinet, 2005, Silencing of the CaV3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception., Embo J, 24, 315, 10.1038/sj.emboj.7600515 · DOI · Paper page
  5. Chemin, 2002, Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability., J Physiol, 540, 3, 10.1113/jphysiol.2001.013269 · DOI · Paper page
  6. Chemin, 2001, Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide., Embo J, 20, 7033, 10.1093/emboj/20.24.7033 · DOI · Paper page
  7. Chen, 2003, Abnormal coronary function in mice deficient in alpha1H T-type Ca2 channels., Science, 302, 1416, 10.1126/science.1089268 · DOI · Paper page
  8. Chen, 2010, Ca(v)3.2 T-type Ca2 channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain., J Neurosci, 30, 10360, 10.1523/JNEUROSCI.1041-10.2010 · DOI · Paper page
  9. Choe, 2011, TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent., Mol Pharmacol, 80, 900, 10.1124/mol.111.073205 · DOI · Paper page
  10. Choi, 2007, Attenuated pain responses in mice lacking Ca(v)3.2 T-type channels., Genes Brain Behav, 6, 425, 10.1111/j.1601-183X.2006.00268.x · DOI · Paper page
  11. Descoeur, 2011, Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors., EMBO Mol Med, 3, 1, 10.1002/emmm.201100134 · DOI · Paper page
  12. Dreyfus, 2009, Selective T-type calcium channel block in thalamic neurons reveals channel redundancy and physiological impact of I(T)window., J Neurosci, 30, 99, 10.1523/JNEUROSCI.4305-09.2010 · DOI · Paper page
  13. Dubreuil, 2004, Role of T-type calcium current in identified D-hair mechanoreceptor neurons studied in vitro., J Neurosci, 24, 8480, 10.1523/JNEUROSCI.1598-04.2004 · doi:10.1523/jneurosci.1598-04.2004
  14. Hildebrand, 2006, Contributions of T-type Ca channels to the pathophysiology of pain signaling., Drug Discov Today Dis Mech, 3, 335, 10.1016/j.ddmec.2006.10.001 · DOI
  15. Hondeghem, 1984, Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs., Annu Rev Pharmacol Toxicol, 24, 387, 10.1146/annurev.pa.24.040184.002131 · DOI · Paper page
  16. Jacus, 2012, Presynaptic CaV3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons., J Neurosci, 32, 9374, 10.1523/JNEUROSCI.0068-12.2012 · DOI · Paper page
  17. Jagodic, 2008, Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve., J Neurophysiol, 99, 3151, 10.1152/jn.01031.2007 · DOI · Paper page
  18. Jagodic, 2007, Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons., J Neurosci, 27, 3305, 10.1523/JNEUROSCI.4866-06.2007 · DOI · Paper page
  19. Jimenez, 2000, Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels., Neuropharmacology, 39, 1, 10.1016/S0028-3908(99)00153-7 · DOI
  20. Kim, 2003, Thalamic control of visceral nociception mediated by T-type Ca2 channels., Science, 302, 117, 10.1126/science.1088886 · DOI · Paper page
  21. Klockner, 1999, Comparison of the Ca2 currents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and alpha1I, of low-voltage-activated T-type Ca2 channels., Eur J Neurosci, 11, 4171, 10.1046/j.1460-9568.1999.00849.x · DOI · Paper page
  22. Kraus, 2010, In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice., J Pharmacol Exp Ther, 335, 409, 10.1124/jpet.110.171058 · DOI
  23. Liao, 2011, Involvement of the CaV3.2 T-type calcium channel in thalamic neuron discharge patterns., Mol Pain, 7, 43, 10.1186/1744-8069-7-43 · DOI
  24. Marger, 2011, T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome., Proc Natl Acad Sci USA, 108, 11268, 10.1073/pnas.1100869108 · DOI · Paper page
  25. Martin, 2000, Mibefradil block of cloned T-type calcium channels., J Pharmacol Exp Ther, 295, 302, 10.1016/S0022-3565(24)38902-5 · DOI · Paper page
  26. Matsunami, 2009, Luminal hydrogen sulfide plays a pro-nociceptive role in mouse colon., Gut, 58, 751, 10.1136/gut.2007.144543 · DOI · Paper page
  27. McDonough, 1998, Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons., Mol Pharmacol, 54, 1080, 10.1124/mol.54.6.1080 · DOI
  28. Messinger, 2009, In vivo silencing of the Ca(v)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy., PAIN, 145, 184, 10.1016/j.pain.2009.06.012 · DOI · Paper page
  29. Na, 2008, Attenuated neuropathic pain in Ca(v)3.1 null mice., Mol Cells, 25, 242, 10.1016/S1016-8478(23)17576-5 · DOI
  30. Necker, 1978, Noxious thermal input from the rat tail: modulation by descending inhibitory influences., PAIN, 4, 231, 10.1016/0304-3959(77)90135-X · DOI · Paper page
  31. Nelson, 2005, The endogenous redox agent l-cysteine induces T-type Ca2 channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors., J Neurosci, 25, 8766, 10.1523/JNEUROSCI.2527-05.2005 · DOI · Paper page
  32. Nelson, 2007, Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels., J Neurosci, 27, 8250, 10.1523/JNEUROSCI.1800-07.2007 · DOI
  33. Okubo, 2011, Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats., Neuroscience, 188, 148, 10.1016/j.neuroscience.2011.05.004 · DOI
  34. Park, 2010, T-type channels control the opioidergic descending analgesia at the low threshold-spiking GABAergic neurons in the periaqueductal gray., Proc Natl Acad Sci USA, 107, 14857, 10.1073/pnas.1009532107 · DOI
  35. Perez-Reyes, 2003, Molecular physiology of low-voltage-activated T-type calcium channels., Physiol Rev, 83, 117, 10.1152/physrev.00018.2002 · DOI · Paper page
  36. Ross, 2008, Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol., J Biol Chem, 283, 16124, 10.1074/jbc.M707104200 · DOI · Paper page
  37. Shin, 2008, T-type Ca2 channels as therapeutic targets in the nervous system., Curr Opin Pharmacol, 8, 33, 10.1016/j.coph.2007.12.003 · DOI
  38. Shin, 2003, A T-type calcium channel required for normal function of a mammalian mechanoreceptor., Nat Neurosci, 6, 724, 10.1038/nn1076 · DOI
  39. Takahashi, 2010, Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain., PAIN, 150, 183, 10.1016/j.pain.2010.04.022 · DOI
  40. Talley, 1999, Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels., J Neurosci, 19, 1895, 10.1523/JNEUROSCI.19-06-01895.1999 · DOI · Paper page
  41. Todorovic, 2001, Redox modulation of T-type calcium channels in rat peripheral nociceptors., Neuron, 31, 75, 10.1016/S0896-6273(01)00338-5 · DOI · Paper page
  42. Todorovic, 2004, Redox modulation of peripheral T-type Ca2 channels in vivo: alteration of nerve injury-induced thermal hyperalgesia., PAIN, 109, 328, 10.1016/j.pain.2004.01.026 · DOI
  43. Uebele, 2009, Antagonism of T-type calcium channels inhibits high-fat diet - induced weight gain in mice., J Clin Invest, 119, 1659, 10.1172/JCI36954 · DOI
  44. Uebele, 2009, Positive allosteric interaction of structurally diverse T-type calcium channel antagonists., Cell Biochem Biophys, 55, 81, 10.1007/s12013-009-9057-4 · DOI
  45. Wang, 2011, The CaV3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors., J Physiol, 589, 2229, 10.1113/jphysiol.2010.203463 · DOI
  46. Zamponi, 2009, Role of voltage-gated calcium channels in ascending pain pathways., Brain Res Rev, 60, 84, 10.1016/j.brainresrev.2008.12.021 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
Francois, A., Kerckhove, N., Meleine, M., Alloui, A., Barrere, C., Gelot, A., Uebele, V. N., Renger, J. J., Eschalier, A., Ardid, D., & Bourinet, E.
Venue
Pain
Published
2013-02
Volume
154
Issue
2
Pages
283-293
ISSN
0304-3959 (ISSN-L)
OpenAlex
W2059306741
Cited by
120
References
3
FWCI
4.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects. https://app.cochat.ai/papers/10.1016/j.pain.2012.10.023
The paper
Francois, A., Kerckhove, N., Meleine, M., Alloui, A., Barrere, C., Gelot, A., Uebele, V. N., Renger, J. J., Eschalier, A., Ardid, D., & Bourinet, E. (2013). State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects. Pain. https://doi.org/10.1016/j.pain.2012.10.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.